Crossmark

Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

Crossref DOI link: https://doi.org/10.1038/s41436-020-0883-5

Published Print: 2020-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mesman, Romy L.S. https://orcid.org/0000-0002-2932-5226
Calléja, Fabienne M.G.R.

de la Hoya, Miguel

Devilee, Peter

van Asperen, Christi J.

Vrieling, Harry

Vreeswijk, Maaike P.G.
License Information

Text and Data Mining valid from 2020-08-01

Text and Data Mining valid from 2020-08-01

Version of Record valid from 2021-11-24
More Information

This article is maintained by: Elsevier

Article Title: Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41436-020-0883-5

CrossRef DOI link to the associated document: https://doi.org/10.1038/s41436-020-0814-5

Content Type: article

Copyright: © 2020, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics